BioSpace News Archive

Drug Development

Novel Drug Treatment Shows Improved Cognition in a Phase 3 Clinical Trial in Persons with Mild-to-Moderate Alzheimer’s Disease in China

Green Valley Pharmaceutical Company has submitted New Drug Applications and Market Authorization to China Food and Drug Administration (CFDA) for Sodium Oligomannurarate (GV-971)

October 25, 2018
·
5 min read
Policy

Calidi Biotherapeutics, Inc. Granted New Patent from USPTO for Cell-Based Delivery Of Oncolytic Vaccinia Viruses

Calidi Biotherapeutics, Inc. today announced that it has been granted a new patent from the United States Patent Office (USPTO).

October 25, 2018
·
2 min read
Business

Mercaptor Announces the Appointment of World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board

Mercaptor Discoveries announced today that Dr. Adriano Aguzzi, MD, PhD, is heading up the formation of its Scientific Advisory Board (SAB). D

October 25, 2018
·
3 min read
Business

Celgene Corporation Chairman & CEO Mark J. Alles to Deliver Keynote Address at 2018 Washington State Life Science Summit

Chairman & CEO Mark Alles of Celgene to deliver keynote speech at Washington State Life Science Summit

October 25, 2018
·
1 min read
Business

Novocure Reports Third Quarter 2018 Financial Results and Provides Company Update

Quarterly net revenues of $64.8 million, representing 29 percent growth versus the third quarter 2017 and 5 percent growth versus the second quarter 2018

October 25, 2018
·
12 min read
Business

Concert Pharmaceuticals to Report Third Quarter 2018 Financial Results on November 1, 2018

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its third quarter 2018 financial results on Thursday, November 1, 2018,

October 25, 2018
·
1 min read
Business

CTI BioPharma to Report Third Quarter 2018 Financial Results on November 1, 2018

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its third quarter 2018 financial results on Thursday, November 1, 2018,

October 25, 2018
·
1 min read
BioMidwest

Taking Back Prescriptions, Giving Back Wellness

HealthSource Rewards Americans Participating in the DEA’s Take Back Day with Wellness Vouchers

October 25, 2018
·
2 min read
Integrated Cannabis Company, Inc. Enters Into Licensing Agreement for Cannabidiol (CBD) Gummy Formulation

Integrated Cannabis Company, Inc. (CSE: ICAN) (OTCQB: ICNAF) (“Integrated Cannabis”), is pleased to announce an agreement to license Cannabidiol (CBD) formulated gummies.

October 25, 2018
·
3 min read
Aurora Cannabis Receives First Cannabis Import Permit from Polish Ministry of Health

Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that Polish Ministry of Health granted the Company approval for its first shipment of medical cannabis to Poland.

October 25, 2018
·
5 min read